WFORCE | sciencenewsnet.in

Breaking News

Rising hospital closures disproportionately affect disadvantaged communities

Scientists discover higher levels of CO2 increase survival of viruses in the air and transmission risk

Recovering phosphorus from sewage sludge ash

Genetic hope in fight against devastating wheat disease

CHLA Physician-Scientist Hosts Event Inviting Families to Dispose of Unwanted Medications

These jacks-of-all-trades are masters, too: Yeast study helps answer age-old biology question

Living with Stage 3 lung cancer in your 80s and 90s

ETRI published Key International Standards for Wearable Healthcare

Study Unveils Balance of AI and Preserving Humanity in Health Care

Press Registration for the ASRS 2024 Annual Scientific Meeting Now Open

26 Apr, 2024

WFIRM researchers create specific cancer organoid system to study bacterial effects on immunotherapy

July 29, 2022 sarah JonasResearch Results

Wake Forest Institute for Regenerative Medicine (WFIRM) researchers are using a tumor organoid system to examine the effects of metabolites secreted by bacteria on a specialized immunotherapy – immune checkpoint blockage, a promising cancer treatment development – to determine why some patients don’t respond or develop a resistance to the treatment over time.